68
Participants
Start Date
July 1, 2019
Primary Completion Date
October 10, 2024
Study Completion Date
October 10, 2024
Gemcitabine
Gemcitabine (1000 mg/m2) in 250-500 ml 0.9% saline every three weeks on days 1 and 8 intravenously
Cisplatin
Cisplatin (25 mg/m2) every three weeks on days 1 and 8 intravenously, in 1000 ml 0.9% saline with KCl 20 mmol and MgSO4 8 mmol during the one hour cisplatin infusion followed by 500 ml 0.9% saline over 30 minutes prior to gemcitabine; with adequate pre- and posthydration
Oncologically radical margin-free (R0) resection
Oncologically radical margin-free (R0) resection
Adjuvant chemotherapy
Can be selected by Investigator's Choice
Krankenhaus Nordwest gGmbH, Frankfurt
Collaborators (1)
German Research Foundation
OTHER
Krankenhaus Nordwest
OTHER